GA
GILD icon

Greenspring Advisors’s Gilead Sciences GILD Stock Holding History

Greenspring Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Sell
3,135
-80
-2% -$10.5K 0.02% 228
2026
Q1 		$448K Sell
3,215
-563
-15% -$78.8K 0.03% 188
2025
Q4 		$464K Buy
+3,778
New +$459K 0.03% 179

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Greenspring Advisors's GILD Position: Q2 2026 in Review

Greenspring Advisors reduced its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, selling an estimated $10.5K and leaving 3,135 shares worth $396K. The position accounts for 0.02% of the portfolio, ranked #228.

Greenspring Advisors first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $464K in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Greenspring Advisors held 3,135 shares of Gilead Sciences worth $396K as of Q2 2026.
  • Greenspring Advisors sold 80 Gilead Sciences shares in Q2 2026, an estimated $10.5K.
  • Gilead Sciences made up 0.02% of Greenspring Advisors's portfolio in Q2 2026, its #228 holding.
  • Greenspring Advisors first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Greenspring Advisors's Gilead Sciences position peaked at $464K in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Greenspring Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.